David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 2,000 shares at $86.28 ($173K) on 2019-05-01, disclosed to the SEC on 2019-05-03.
Seasonal sale ($173k) by Chief Medical Officer — this insider has traded ICPT in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |
| ICPT | SELL | 2019-01-04 | $46K | — | Filing → |